Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FBC34
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,155
Award facts
- Contract value 100% obligated
- $45,154.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $45,154.56, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in 60-dose units. The contract represents a firm fixed price delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This award involved no set-aside designation and was competitively awarded through open competition.
The delivery order is scheduled for ultimate completion on August 5, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. Trelegy Ellipta is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease and asthma, reflecting the comprehensive therapeutic breadth of pharmaceutical products that AmerisourceBergen supplies through its federal contract portfolio. The firm fixed pricing structure and rapid completion timeline are consistent with the company's established role as a critical vendor for federal military healthcare operations and its demonstrated capability to fulfill time-sensitive pharmaceutical delivery requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FBC34?
SPE2DB25FBC34 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FBC34 worth?
The government has obligated $45,155 on SPE2DB25FBC34.
Is contract SPE2DB25FBC34 an order under another contract?
Yes. SPE2DB25FBC34 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBC34 competed?
The extent of competition for SPE2DB25FBC34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award